Developer docs
API playgroundTry for free, no card

Search company profiles

Flexogenix

Full company profile

uuid002h7h6

Namestring
Flexogenix
Websiteurl
flexogenix.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Flexogenix is a private, for-profit U.S. healthcare services company headquartered in Cary, North Carolina, founded in 2013. According to the firm's own description, it specializes in providing minimally invasive, cost-effective, non-surgical solutions — specifically in the orthopedic pain management category, with a focus on knee osteoarthritis and related joint conditions, as suggested by the operation of the arthritiskneepain.com consumer web property.

The company's core offering is a clinical, non-surgical procedure protocol for patients suffering from chronic knee pain, positioned as an alternative to invasive surgical interventions such as knee replacement. The underlying technology is centered on proprietary injection-based or regenerative treatment protocols delivered in an outpatient clinic setting; no proprietary software, AI models, or digital platforms are disclosed. The company appears to rely on a consumer-facing marketing channel in addition to physician referrals to drive patient acquisition.

Operationally, Flexogenix has scaled to 101-250 employees, consistent with a multi-site clinic model across multiple U.S. geographies. The revenue model is direct-to-consumer healthcare services, with payment likely coming from a mix of patient out-of-pocket spend and third-party reimbursement. No public pricing, payer mix, funding, or financial disclosures are available in the current data set.

Short descriptiontext

Flexogenix is a private U.S. healthcare services company founded in 2013 and headquartered in Cary, NC, providing minimally invasive, non-surgical treatments for chronic knee pain, primarily to patients with knee osteoarthritis seeking alternatives to surgery.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCary, United States
HQ citystring
Cary
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
non-surgical knee treatment, minimally invasive orthopedics, arthritis pain therapy, joint pain management, outpatient orthopedic services
Industry3 codes
PRIMARYHLAKALAH
Hip & Knee Reconstruction (Arthroplasty)
SECONDARYHLAKALAA
General Orthopedics
SECONDARYHLAKALAM
Pain Management (Spine & Musculoskeletal)
NAICS code2 codes
  • Other Ambulatory Health Care Services6219
  • Freestanding Ambulatory Surgical and Emergency Centers621493
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic Pain Management Services
Social media profiles1 record
Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Flexogenix operates outpatient clinics that deliver minimally invasive, non-surgical treatments for chronic knee pain caused by osteoarthritis and related joint conditions. Its services include image-guided injections and other regenerative-style therapies aimed at relieving pain and restoring mobility without the downtime of knee-replacement surgery.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Non-Surgical Knee Pain Treatment
CategoryOrthopedic Pain Management
Description

Minimally invasive, non-surgical knee pain therapy delivered at Flexogenix clinics for adult patients with osteoarthritis or chronic knee joint pain who want to avoid knee-replacement surgery.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Large outpatient rehabilitation chain increasingly offering non-surgical conservative-care programs for knee osteoarthritis; adjacent competitor in the conservative orthopedic pathway.

TypeDirect peer
Description

National network of clinics offering non-surgical orthopedic treatments including regenerative injections for knee and joint pain; competes directly with Flexogenix for patients seeking alternatives to joint replacement.

TypeBroad incumbent
Description

Large multi-specialty orthopedic group adding non-surgical and regenerative options across the Mid-Atlantic and Florida; competes for the same knee-pain patient pool with broader service portfolio.

TypeBroad incumbent
Description

Premier orthopedic hospital that has expanded non-surgical and biologic offerings for knee arthritis; represents the established incumbent whose surgical franchise Flexogenix is positioned against.

TypeBroad incumbent
Description

Major health system offering comprehensive orthopedic care including non-surgical knee pain management; represents large-system competition with payer integration and brand scale advantages.

TypeRegional player
Description

Regional regenerative-medicine clinic in the Northeast offering non-surgical orthopedic treatments including knee injections; comparable service mix but geographically concentrated.

7Genicular Artery Embolization (GAE) providers (e.g., Vascular Institute of the Midwest)
TypeDirect peer
Description

Interventional radiology practices offering genicular artery embolization as a minimally invasive knee arthritis treatment; overlaps with Flexogenix's core procedural modality.

TypeDirect peer
Description

Outpatient practice specializing in non-surgical knee pain relief through viscosupplementation and related injections; direct competitor serving similar demographic with comparable treatment philosophy.

TypeDirect peer
Description

Multi-site clinic brand offering non-surgical, image-guided treatments for knee osteoarthritis; shares Flexogenix's direct-to-patient knee-pain positioning and consumer-marketing approach.

10StemCell Institute (Panama)
TypeEmerging player
Description

Stem-cell treatment provider for orthopedic and joint conditions including knee arthritis; competes for medical-tourism and cash-pay patients seeking regenerative alternatives to surgery.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Flexogenix

Orthopedic Pain Management Servicesflexogenix.com

Flexogenix is a private U.S. healthcare services company founded in 2013 and headquartered in Cary, NC, providing minimally invasive, non-surgical treatments for chronic knee pain, primarily to patients with knee osteoarthritis seeking alternatives to surgery.

What Flexogenix does

Flexogenix is a private, for-profit U.S. healthcare services company headquartered in Cary, North Carolina, founded in 2013. According to the firm's own description, it specializes in providing minimally invasive, cost-effective, non-surgical solutions — specifically in the orthopedic pain management category, with a focus on knee osteoarthritis and related joint conditions, as suggested by the operation of the arthritiskneepain.com consumer web property.

The company's core offering is a clinical, non-surgical procedure protocol for patients suffering from chronic knee pain, positioned as an alternative to invasive surgical interventions such as knee replacement. The underlying technology is centered on proprietary injection-based or regenerative treatment protocols delivered in an outpatient clinic setting; no proprietary software, AI models, or digital platforms are disclosed. The company appears to rely on a consumer-facing marketing channel in addition to physician referrals to drive patient acquisition.

Operationally, Flexogenix has scaled to 101-250 employees, consistent with a multi-site clinic model across multiple U.S. geographies. The revenue model is direct-to-consumer healthcare services, with payment likely coming from a mix of patient out-of-pocket spend and third-party reimbursement. No public pricing, payer mix, funding, or financial disclosures are available in the current data set.

Flexogenix firmographics

Firmographics
Name
Flexogenix
Website
https://flexogenix.com
Company type
Private
Founded year
2013
Headcount range
11–50 employees
Short description
Flexogenix is a private U.S. healthcare services company founded in 2013 and headquartered in Cary, NC, providing minimally invasive, non-surgical treatments for chronic knee pain, primarily to patients with knee osteoarthritis seeking alternatives to surgery.
Ownership category
akta.pro rank

Flexogenix industry classification

Industry
Product category
Orthopedic Pain Management Services
NAICS
Other Ambulatory Health Care Services (6219), Freestanding Ambulatory Surgical and Emergency Centers (621493)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAKALAH
Hip & Knee Reconstruction (Arthroplasty)
SECONDARYHLAKALAA
General Orthopedics
SECONDARYHLAKALAM
Pain Management (Spine & Musculoskeletal)

Keywords

  • Non-surgical knee treatment
  • Minimally invasive orthopedics
  • Arthritis pain therapy
  • Joint pain management
  • Outpatient orthopedic services

Where Flexogenix is headquartered

Location

Headquarters

HQ city
Cary
HQ country
United States
HQ region
North America

Markets served

Flexogenix business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Flexogenix product offering

Product offering

Core offering

Flexogenix operates outpatient clinics that deliver minimally invasive, non-surgical treatments for chronic knee pain caused by osteoarthritis and related joint conditions. Its services include image-guided injections and other regenerative-style therapies aimed at relieving pain and restoring mobility without the downtime of knee-replacement surgery.

Differentiator

Problem solved

Functional benefit

Products and services

  • Non-Surgical Knee Pain Treatment Minimally invasive, non-surgical knee pain therapy delivered at Flexogenix clinics for adult patients with osteoarthritis or chronic knee joint pain who want to avoid knee-replacement surgery.

Companies that use Flexogenix

Customer profile

Ideal customer profiles1 record

Flexogenix technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Flexogenix partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights3 records

Flexogenix competitors and assessment

Company assessment

Emerging players

  • Athletico Physical Therapy: Large outpatient rehabilitation chain increasingly offering non-surgical conservative-care programs for knee osteoarthritis; adjacent competitor in the conservative orthopedic pathway.
  • StemCell Institute (Panama): Stem-cell treatment provider for orthopedic and joint conditions including knee arthritis; competes for medical-tourism and cash-pay patients seeking regenerative alternatives to surgery.

Direct peers

  • Regenexx: National network of clinics offering non-surgical orthopedic treatments including regenerative injections for knee and joint pain; competes directly with Flexogenix for patients seeking alternatives to joint replacement.
  • Genicular Artery Embolization (GAE) providers (e.g., Vascular Institute of the Midwest): Interventional radiology practices offering genicular artery embolization as a minimally invasive knee arthritis treatment; overlaps with Flexogenix's core procedural modality.
  • Joint Relief Institute: Outpatient practice specializing in non-surgical knee pain relief through viscosupplementation and related injections; direct competitor serving similar demographic with comparable treatment philosophy.
  • Arthritis Knee Pain Centers: Multi-site clinic brand offering non-surgical, image-guided treatments for knee osteoarthritis; shares Flexogenix's direct-to-patient knee-pain positioning and consumer-marketing approach.

Broad incumbents

  • Rothman Orthopaedic Institute: Large multi-specialty orthopedic group adding non-surgical and regenerative options across the Mid-Atlantic and Florida; competes for the same knee-pain patient pool with broader service portfolio.
  • Hospital for Special Surgery (HSS): Premier orthopedic hospital that has expanded non-surgical and biologic offerings for knee arthritis; represents the established incumbent whose surgical franchise Flexogenix is positioned against.
  • Cleveland Clinic Orthopaedic & Rheumatologic Institute: Major health system offering comprehensive orthopedic care including non-surgical knee pain management; represents large-system competition with payer integration and brand scale advantages.

Regional players

  • NYC Stem Cell / Regenexx NY: Regional regenerative-medicine clinic in the Northeast offering non-surgical orthopedic treatments including knee injections; comparable service mix but geographically concentrated.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Flexogenix social profiles

Digital presence

Flexogenix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Flexogenix leadership team

Management profile

Number of profiles

Flexogenix funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Flexogenix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Flexogenix

What does Flexogenix do?

Flexogenix operates outpatient clinics that deliver minimally invasive, non-surgical treatments for chronic knee pain caused by osteoarthritis and related joint conditions. Its services include image-guided injections and other regenerative-style therapies aimed at relieving pain and restoring mobility without the downtime of knee-replacement surgery.

When was Flexogenix founded?

Flexogenix was founded in 2013. It employs 11 to 50 people.

Where is Flexogenix based?

Flexogenix is headquartered in Cary, United States, in the North America region.

Who are Flexogenix's main competitors?

Emerging players on record are Athletico Physical Therapy and StemCell Institute (Panama). Direct peers are Regenexx, Genicular Artery Embolization (GAE) providers (e.g., Vascular Institute of the Midwest), Joint Relief Institute and Arthritis Knee Pain Centers. Broad incumbents are Rothman Orthopaedic Institute, Hospital for Special Surgery (HSS) and Cleveland Clinic Orthopaedic & Rheumatologic Institute. NYC Stem Cell / Regenexx NY is listed as a regional player.

Does Flexogenix have an API?

No public API is recorded for Flexogenix.

What industry is Flexogenix in?

Flexogenix's product category is Orthopedic Pain Management Services. Its primary akta.pro industry code is HLAKALAH, Hip & Knee Reconstruction (Arthroplasty), with a secondary code of HLAKALAA, General Orthopedics. Its NAICS code is 6219 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales